NCT01604044View on ClinicalTrials.gov

Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.

PHASE1CompletedINTERVENTIONAL
Enrollment

579

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Female Infertility
Interventions
DRUG

Meropur 150 a day

one subcutaneous injection a day

DRUG

Gonal-f 150 plus Luveris 150

one subcutaneous injection a day

Trial Locations (1)

00168

Policlinico Agostino Gemelli, Rome

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER

NCT01604044 - Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial. | Biotech Hunter | Biotech Hunter